Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Other financing activities (2021 - 2022)

Historic Other financing activities for Prime Medicine (PRME) over the last 2 years, with Q4 2022 value amounting to $1.4 million.

  • Prime Medicine's Other financing activities rose 2891.34% to $1.4 million in Q4 2022 from the same period last year, while for Sep 2023 it was $1.4 million, marking a year-over-year decrease of 6244.64%. This contributed to the annual value of $4.0 million for FY2022, which is 27219.15% up from last year.
  • Latest data reveals that Prime Medicine reported Other financing activities of $1.4 million as of Q4 2022, which was up 2891.34% from $746000.0 recorded in Q3 2022.
  • Prime Medicine's 5-year Other financing activities high stood at $1.4 million for Q4 2022, and its period low was $624000.0 during Q2 2022.